BLADDER HYDRODISTENSION IN TREATING PATIENTS WITH INTERSTYTIAL CYSTITIS/ BLADDER PAIN SYNDROME
- Authors: Al'-Shukri S.K.1, Kuz'min I.V1, Slesarevskaya M.N1, Ignashov Y.A1
-
Affiliations:
- First Pavlov State Medical University of St. Petersburg
- Issue: No 1 (2018)
- Pages: 26-29
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/322066
- DOI: https://doi.org/10.18565/urology.2018.1.26-29
- ID: 322066
Cite item
Abstract
Full Text
About the authors
S. Kh Al'-Shukri
First Pavlov State Medical University of St. Petersburg
Email: urolog.kaf@mail.ru
Dr.Med.Sci., Prof., Head of the Department of Urology St. Petersburg, Russia
I. V Kuz'min
First Pavlov State Medical University of St. Petersburg
Email: kuzminigor@mail.ru
Dr.Med.Sci., Prof. at the Department of Urology St. Petersburg, Russia
M. N Slesarevskaya
First Pavlov State Medical University of St. Petersburg
Email: mns-1971@yandex.ru
Ph.D., Senior Researcher at the Department of Urology
Yu. A Ignashov
First Pavlov State Medical University of St. Petersburg
Email: yuri.ignashov@gmail.com
Ph.D. Student at the Department of Urology St. Petersburg, Russia
References
- Fall M., Baranowski A.P., Elneil S. EAU Guidelines on Chronic Pelvic Pain. Eur Urol. 2010;57:35-48.
- Davis N.F., Brady C.M., Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30-37. doi: 10.1016/j.ejogrb.2013.12.041.
- Slesarevskaya M.N., Kuz'min I.V., Ignashov Yu.A. Characteristics of symptoms and psychosomatic status in women with chronic pelvic pain syndrome. Urologicheskie vedomosti. 2015;5(3):16-19.
- Kryuchkova M.N., Soldatkin V.A. Syndrome of chronic pelvic pain: psychopathological aspects. Vestnik urologii. 2017;5(1):52-63.
- Loran O.B., Sinyakova L.A., Mitrohin A.A, Plesovskij A.M., Shtejnberg M.L., Vinarova N.A. A modern approach to the problem of interstitial cystitis. Meditsinskij sovet. 2011;11:15-19.
- Jhang J.F., Kuo H.C. Pathomechanism of interstitial cystitis/ bladder pain syndrome and mapping the heterogeneity of disease. Int Neurourol J. 2016;20(SuppI. 2):S95-104. Doi: 10.5213/ inj.1632712.356.
- van de Merwe J.P., Nordling J., Bouchelouche P., Bouchelouche K., Cervigni M., Daha L.K. et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60-67. Doi: 10.1016/j. eururo.2007.09.019.
- Zaitsev A.V., Sharov M.N., Ibragimov R.A., Nahrapov D.I., Pushkar D.Yu. Painful bladder syndrome/interstitial cystitis: modern approaches to diagnosis and treatment. Vrach skoroj pomoshchi. 2015;(7):32-42.
- Slesarevskaya M.N., Ignashov Yu.A., Kuz'min I.V. Current approaches to the diagnostic ofbladder pain syndrome. Urologicheskie vedomosti. 2017;7(2):25-30.
- Al-Shukri S.H., Kuz'min I.V., Shabudina N.O., Slesarevskaya M.N., Ignashov Yu.A. The role of vasoactive drugs in the treatment and rehabilitation of women with chronic pelvic pain syndrome. Regionarnoe krovoobrashhenie i mikrocirkuljacija. 2017; 16(2):25- 31
- Olson L.E., Dyer J.E., Haq A., Ockrim J., Greenwell T.J. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecol J. 2017. doi: 10.1007/s00192-017-3355-y.
- Lorenzo L., Bonillo M.A., Arlandis S., Martinez-Cuenca E., Marzullo L., Broseta E., BoronatF. Hydrodistension plus Onabotulinumtoxin A in bladder pain syndrome refractory to conservative treatments. Actas Urol Esp. 2016;40(5):303-308. doi: 10.1016/j.acuro.2015.12.011.
- Rigaud J., Delavierre D., Sibert L., Labat J.J. Hydrodistension in the therapeutic management of painful bladder syndrome. Prog Urol. 2010;20(12):1054-1059.
- Niimi A., Nomiya A., Yamada Y., Suzuki M., Fujimura T., Fukuhara H., Kume H., Igawa Y., Homma Y. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Longterm outcomes and prognostic predictors. Neurourol Urodyn. 2016;35(8):965-969. doi: 10.1002/nau.22837.
- Chai T.C. Bladder stretch alters urinary heparinbindung epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J. Urol. 2002;63:1440-1444.
- Glemain P. Prolonged hydrodistension of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol. 2002;41:79-84.
- Turner K.J., Stewart L.H. How do you stretch a bladder? A survey of UK practice, a literature review, and a recommendation of a standard approach. Neurourol Urodyn. 2005;24:74-76.